Skip to content
verana-health-logo-inverted
  • Clinicians
    • MIPS Advisory Offerings
    • Practice Insights
    • Verana Trial Connect
    • Verana Quality Measures
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Therapeutic Area
    • Oncology
      • Acute Myeloid Leukemia
      • Bladder Cancer
      • Breast Cancer
      • Chronic Lymphocytic Leukemia
      • Colorectal Cancer
      • Follicular Lymphoma
      • Large B-Cell Lymphoma
      • Lung Cancer
      • Marginal Zone Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myelodysplastic Syndrome
      • Ovarian Cancer
      • Prostate Cancer
    • Ophthalmology
      • Anti-VEGF
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinal Vein Occlusion
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
    • Urology
      • Bladder Cancer
      • Prostate Cancer
    • Neurology
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
  • Solutions
    • Clinical Research Solutions
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Clinical Trials
      • Site Explorer
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
  • About Us
    • About
      • Evolve Registry
    • Team
    • Resources
    • Careers
    • Partners
      • Societies
      • CROs
      • Technology and Data
    • Privacy
      • Privacy Policy
      • Patient Privacy
Contact Us

Press

Verana Health Named Growth and Innovation Leader in 2025 Frost Radar™ for Life Sciences Real-World Evidence Solutions

January 22, 2026
Read More...

Verana Health Enhances Site Explorer Tool to Expedite Urology Clinical Trials

January 15, 2026
Read More...

Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties

January 8, 2026
Read More...

Verana Health Enhances MIPS Advisory Services to Help Medical Practices to Maximize Program Benefits, Reduce Compliance Burden, and Improve Patient Care 

October 7, 2025
Read More...

Verana Health Introduces Significant Data and Software Enhancements to Support Ophthalmologic Research and Treatment Optimization

October 2, 2025
Read More...

Verana Health Launches Qdata® Cataracts, the Largest Dataset of Its Kind for Cataract Research

April 23, 2025
Read More...

Verana Health Enhances Site Explorer Tool to Advance Diversity in Clinical Trials 

March 4, 2025
Read More...

Verana Health and Nanoscope Therapeutics Announce Collaboration to Accelerate Retinitis Pigmentosa Research

February 25, 2025
Read More...

Verana Health Debuts Qdata Explorer in Advance of American Academy of Ophthalmology 2024 Annual Meeting

October 9, 2024
Read More...

Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of Ophthalmology Annual Meeting

October 8, 2024
Read More...
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 26
  • Next »
verana-health-logo-inverted

© 2026 Verana Health. All Rights Reserved.

San Francisco
New York
Knoxville
  • Privacy Policy
  • Cookie Policy
Back to Top